Rhinitis, Vasomotor

Approved for this indication (5)

• azelastine
• cyproheptadine
• dexchlorpheniramine maleate
• carbinoxamine maleate
• rotoxamine

Phase 4 trials (1)

• olopatadine

Phase 3 trials (4)

• phenylephrine
• fluticasone
• levocetirizine
• pseudoephedrine

Other trials (4)

• mometasone
• sodium chloride
• esomeprazole
• oxymetazoline

Organization Involved with Phase 4 Indications (1)

• Alcon

Organization Involved with Phase 3 Indications (3)

• Bayer
• GlaxoSmithKline
• Hanmi Pharmaceutical

Organization Involved with Other Experimental Indications (2)

• AstraZeneca
• The University of Texas, Dallas